Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang,  Depatment of Physical Therapy, Korea Natiional University of Transportation,  South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

  • Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
    Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
    Year: 2025

 

  • Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
    Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
    Year: 2025

 

  • Title: Usability Test for a Cane-Combined Weight Support Feedback Device
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2024

 

  • Title: Usability Test for Motion Tracking Gait Assistive Walker
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2023

 

  • Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

  • Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr.  CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA,  Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

 

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

  • Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
    Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
    Year: 2025

 

  • Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
    Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
    Year: 2024

 

  • Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
    Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
    Year: 2023

 

  • Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
    Year: 2023

 

  • Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
    Year: 2023

 

  • Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2023

 

  • Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
    Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
    Year: 2022

 

  • Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
    Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
    Year: 2022

 

  • Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2022

 

  • Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
    Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
    Year: 2021

 

Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.